Hypercoagulation in colorectal cancer: What can platelet indices tell us?

References

• Trousseau A. Phlegmasia alba dolens. Lectures on clinical medicine, delivered at the Holte-Dieu. Paris 1865;5:281–332
   Google Scholar
• Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 2004;104:397–401
   PubMed Web of Science ®Google Scholar
• Sharma D, Brummel-Ziedins KE, Bouchard BA, Holmes CE. Platelets in tumor progression: A host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol 2013 Dec 20. doi: 10.1002/jcp.24539. [Epub ahead of print]
   Google Scholar
• Dovizio M, Alberti S, Guillem-Llobat P, Patrignani P. Role of platelets in inflammation and cancer: Novel therapeutic strategies. Basic Clin Pharmacol Toxicol 2014;114:118–127
   Google Scholar
• Folkman J. Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction. Cancer Metastasis Rev 1990;9:171–174
   PubMed Web of Science ®Google Scholar
• Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WF, Jesty J. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998;75:780–786
   PubMed Web of Science ®Google Scholar
• Sarmiento R, Longo R, Gasparini G. Antiangiogenic therapy of colorectal cancer: State of the art, challenges and new approaches. Int J Biol Markers 2012;27:286–294
   Google Scholar
• Sun W. Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy. J Hematol Oncol 2012;5:63
   PubMed Web of Science ®Google Scholar
• Mao Q, Zhang Y, Fu X, Xue J, Guo W, Meng M, Zhou Z, Mo X, Lu Y. A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy. J Cancer Res Clin Oncol 2013;139:211–222
   PubMed Web of Science ®Google Scholar
• Kwon HC, Kim SH, Oh SY, Lee S, Kwon KA, Choi HJ, Park KJ, Kim HJ, Roh MS. Clinicopathological significance of p53, hypoxia-inducible factor 1alpha, and vascular endothelial growth factor expression in colorectal cancer. Anticancer Res 2010;30:4163–4168
   Google Scholar
• Yonenaga Y, Mori A, Onodera H, Yasuda S, Oe H, Fujimoto A, Tachibana T, Imamura M. Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology 2005;69:159–166
   PubMed Web of Science ®Google Scholar
• Seftor RE, Hess AR, Seftor EA, Kirschmann DA, Hardy KM, Margaryan NV, Hendrix MJ. Tumor cell vasculogenic mimicry: From controversy to therapeutic promise. Am J Pathol 2012;181:1115–1125
   PubMed Web of Science ®Google Scholar
• Shchors K, Evan G. Tumor angiogenesis: Cause or consequence of cancer? Cancer Res 2007;67:7059–7061
   PubMed Web of Science ®Google Scholar
• Saelen MG, Flatmark K, Folkvord S, de Wijn R, Rasmussen H, Fodstad Ø, Ree AH. Tumor kinase activity in locally advanced rectal cancer: Angiogenic signaling and early systemic dissemination. Angiogenesis 2011;14:481–489
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tozzi F, Chen J, Fan F, Xia L, Wang J, Gao G, Zhang A, Xia X, Brasher H, et al. Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells. Cancer Res 2012;72:304–314
   PubMed Web of Science ®Google Scholar
• Jackson SP, Nesbitt WS, Westein E. Dynamics of platelet thrombus formation. J Thromb Haemost 2009;7:17–20
   PubMed Web of Science ®Google Scholar
• Egan K, Crowley D, Smyth P, O'Toole S, Spillane C, Martin C, Gallagher M, Canney A, Norris L, Conlon N, et al. Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS One 2011;6:e26125
   Web of Science ®Google Scholar
• Karshovska E, Weber C, von Hundelshausen P. Platelet chemokines in health and disease. Thromb Haemost 2013;110:894–902
   Google Scholar
• Hamad OA, Bäck J, Nilsson PH, Nilsson B, Ekdahl KN. Platelets, complement, and contact activation: Partners in inflammation and thrombosis. Adv Exp Med Biol 2012;946:185–205
   PubMedGoogle Scholar
• Ionescu C, Berindan-Neagoe I, Burz C, Balacescu O, Balacescu L, Tudoran O, Asztalos R, Irimie A. The clinical implications of platelet derived growth factor B, vascular endothelial growth factor and basic fibroblast growth factor in colorectal cancer. J BUON 2011;16:274–276
   Google Scholar
• Gil-Bazo I, CatalánGoni V, Alonso Gutiérrez A, Rodríguez Rodríguez J, Páramo Fernández JA, de la Cámara Gómez J, Hernández Lizoain JL, García-Foncillas López J. Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancer. Clin Transl Oncol 2005;7:150–155
   Google Scholar
• Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 2003;6:283–287
   PubMedGoogle Scholar
• Baker-Groberg SM, Itakura A, Gruber A, McCarty OJ. Role of coagulation in the recruitment of colon adenocarcinoma cells to thrombus under shear. Am J Physiol Cell Physiol 2013;305:951–959
   Google Scholar
• Ribatti D, Crivellato E, Vacca A. Inflammation and antiangiogenesis in cancer. Curr Med Chem 2012;19:955–960
   Google Scholar
• Buergy D, Wenz F, Groden C, Brockmann MA. Tumor-platelet interaction in solid tumors. Int J Cancer 2012;130:2747–2460
   PubMed Web of Science ®Google Scholar
• Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer 2011;11:123–134
   PubMed Web of Science ®Google Scholar
• Erpenbeck L, Schön MP. Deadly allies: The fatal interplay between platelets and metastasizing cancer cells. Blood 2010;115:3427–3436
   PubMed Web of Science ®Google Scholar
• Negrão R, Duarte D, Costa R, Soares R. Could platelet-accumulating polyphenols prevent tumour metastasis? Nat Rev Cancer 2011;11:685
   Google Scholar
• Suzuki S, Dobashi Y, Hatakeyama Y, Tajiri R, Fujimura T, Heldin CH, Ooi A. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer. BMC Cancer 2010;10:659
   PubMed Web of Science ®Google Scholar
• Varon D, Shai E. Role of platelet-derived microparticles in angiogenesis and tumor progression. Discov Med 2009;8:237–241
   PubMedGoogle Scholar
• Tsuruo T, Fujita N. Platelet aggregation in the formation of tumor metastasis. Proc Jpn Acad Ser B Phys Biol Sci 2008;84:189–198
   PubMed Web of Science ®Google Scholar
• Osada M, Inoue O, Ding G, Shirai T, Ichise H, Hirayama K, Takano K, Yatomi Y, Hirashima M, Fujii H, et al. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Biol Chem 2012;287:22241–22252
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation. J Biochem 2011;150:127–132
   PubMed Web of Science ®Google Scholar
• Placke T, Kopp HG, Salih HR. The wolf in sheep's clothing: Platelet-derived “pseudo self” impairs cancer cell “missing self” recognition by NK cells. Oncoimmunology 2012;1:557–559
   PubMed Web of Science ®Google Scholar
• Placke T, Kopp HG, Salih HR. Modulation of natural killer cell anti-tumor reactivity by platelets. J Innate Immun 2011;3:374–382
   PubMed Web of Science ®Google Scholar
• Abajo A, Bitarte N, Zarate R, Boni V, Lopez I, Gonzalez-Huarriz M, Rodriguez J, Bandres E, Garcia-Foncillas J. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array. World J Gastroenterol 2012;18:637–645
   Google Scholar
• Cao Z, Shang B, Zhang G, Miele L, Sarkar FH, Wang Z, Zhou Q. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis. Biochim Biophys Acta 2013;1836:273–286
   Google Scholar
• Ciurea SO, Hoffman R. Cytokines for the treatment of thrombocytopenia. Semin Hematol 2007;44:166–182
   PubMed Web of Science ®Google Scholar
• Dymicka-Piekarska V, Kemona H. Thrombopoietin and reticulated platelets as thrombopoietic markers in colorectal cancer. Thromb Res 2008;122:141–143
   PubMed Web of Science ®Google Scholar
• Gao W, Chen L, Ma Z, Du Z, Zhao Z, Hu Z, Li Q. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential. Gastroenterology 2013;145:636–646
   Google Scholar
• Kockar C, Kockar O, Ozturk M, Dagli M, Bavbek N, Kosar A. Global fibrinolytic capacity increased exponentially in metastatic colorectal cancer. Clin Appl Thromb Hemost 2005;11:227–230
   Google Scholar
• Ozturk M, Sengul N, Dagli M, Kosar A, Bavbek N. Global fibrinolytic capacity in colorectal cancer: A new clue to occult fibrinolysis. Clin Appl Thromb Hemost 2003;9:151–154
   Google Scholar
• Seretis C, Seretis F, Lagoudianakis E, Politou M, Gemenetzis G, Salemis NS. Enhancing the accuracy of platelet to lymphocyte ratio after adjustment for large platelet count: A pilot study in breast cancer patients. Int J Surg Oncol 2012;2012:653608
   Google Scholar
• Sciulli MG, Filabozzi P, Tacconelli S, Padovano R, Ricciotti E, Capone ML, Grana M, Carnevale V, Patrignani P. Platelet activation in patients with colorectal cancer. Prostaglandins Leukot Essent Fatty Acids 2005;72:79–83
   Google Scholar
• Cravioto-Villanueva A, Luna-Perez P, Gutierrez-de la Barrera M, Martinez-Gómez H, Maffuz A, Rojas-Garcia P, Perez-Alvarez C, Rodriguez-Ramirez S, Rodriguez-Antezana E, Ramirez-Ramirez L. Thrombocytosis as a predictor of distant recurrence in patients with rectal cancer. Arch Med Res 2012;43:305–311
   PubMed Web of Science ®Google Scholar
• Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K. Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer. J Surg Oncol 2012;106:887–891
   PubMed Web of Science ®Google Scholar
• Sasaki K, Kawai K, Tsuno NH, Sunami E, Kitayama J. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World J Surg 2012;36:192–200
   PubMed Web of Science ®Google Scholar
• Wan S, Lai Y, Myers RE, Li B, Hyslop T, London J, Chatterjee D, Palazzo JP, Burkart AL, Zhang K, et al. Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients. J Gastrointest Cancer 2013;44:293–304
   PubMedGoogle Scholar
• Kandemir EG, Mayadagli A, Karagoz B, Bilgi O, Turken O, Yaylaci M. Prognostic significance of thrombocytosis in node-negative colon cancer. J Int Med Res 2005;33:228–235
   PubMed Web of Science ®Google Scholar
• Nyasavajjala SM, Runau F, Datta S, Annette H, Shaw AG, Lund JN. Is there a role for pre-operative thrombocytosis in the management of colorectal cancer? Int J Surg 2010;8:436–438
   PubMed Web of Science ®Google Scholar
• Gyöngyösi M, Strehblow C, Sperker W, Hevesi A, Garamvölgyi R, Petrási Z, Pavo N, Ferdinandy P, Csonka C, Csont T, et al. Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: Prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours. Thromb Haemost 2006;96:202–209
   PubMed Web of Science ®Google Scholar
• Leader A, Pereg D, Lishner M. Are platelet volume indices of clinical use? A multidisciplinary review. Ann Med 2012;44:805–816
   PubMed Web of Science ®Google Scholar
• Mutlu H, Berk V, Karaca H, Erden A, Aslan T, Akca Z. Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer. Clin Appl Thromb Hemost 2012;18:546–548
   Google Scholar